Rday
Thursday, May 14, 2026
33.4
C
Bengaluru
Hot topics
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Novo Nordisk’s Big Reset: What 9,000 Job Cuts Signal for Pharma’s Future
For years, Novo Nordisk was the poster child of growth. Its GLP-1 drugs, Ozempic and Wegovy, didn’t just change obesity treatment — they reshaped the company’s balance sheet. Demand outpaced supply, public awareness skyrocketed, and Novo’s market cap surged.
But growth always attracts challengers. Enter Eli Lilly with Mounjaro and Zepbound, and a wave of competitors and compounded generics threatening margins. Add in slowing sales growth and operational bloat from years of expansion, and suddenly Novo’s leadership had to answer tough questions about sustainability.
Top 25 Indian Pharma Companies by Revenues in 2024
India pharma is crucial for global healthcare, providing affordable...
Pharma CEO Roundtable – Engaging Doctors – Physical, Digital and Hybrid: Translating Strategy into Action
The MedicinMan 10th Anniversary Special - Pharma CEO Roundtable...
Genome Valley: A Signal of Transformation in Indian Pharma?
India’s pharmaceutical sector is at a tipping point. Long...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Hot topics
Boehringer Ingelheim India focuses on partnerships in NCD management
Addressing the media at a roundtable this morning, Vani Manja, Managing Director, Boehringer Ingelheim India said, “Boehringer Ingelheim India aspires to be amongst the top five multinational pharmaceutical companies in India over the next few years. We have been enabling access to our innovator products to patients across India and the neighbouring markets in the diabetes, cardiovascular, stroke and respiratory diseases segments. Our plan in these therapy areas is to build sustainable partnerships to ensure an ecosystem of access and care for patients. We have initiated action in that direction.”
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
The story of Healthium is not just one of...
Biocon Biologics Scores FDA Approval—A Biosimilar Shake-Up for Amgen, Patients, and Investors
Biocon Biologics secures FDA approval for Bosaya™ and Aukelso™,...
How a Delhi Dementia Daycare Is Reimagining Care for India’s Forgotten Millions
By MedicinMan Editorial Desk
When Memory Fades, Humanity Must Not
In...
Dr. Peter Velev, CEO of CredoWeb discussing Digital in Pharma with MedicinMan
The digital revolution is the fourth industrial revolution. It changes models, processes and whole public sectors. In many reports you will find that, in terms of digitalization, pharma is just next to the public sector, as least digitalized. Pharma just started late. There are many reasons for that – it is one of the most regulated industries with lots of sensitive data involved and many ethical aspects. But the slowed down digitalization has a lot to do with some subjective reasons. Adopting digital technologies requires changing existing models which requires a different mindset – and this is difficult to achieve. Nowadays, in the situation of a global pandemic, we see that digital communication is not only necessary to be successful but it is a must in order to adapt to the New Normality.
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Newsletter
Get important news delivered directly to your inbox and stay connected!